218 related articles for article (PubMed ID: 37479943)
1. Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer Registry.
Adachi Y; Asaga S; Kumamaru H; Kinugawa N; Sagara Y; Niikura N; Jinno H; Saji S; Toi M
Breast Cancer Res Treat; 2023 Oct; 201(3):397-408. PubMed ID: 37479943
[TBL] [Abstract][Full Text] [Related]
2. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
4. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 taiwan cancer registry index cases.
Chen BF; Tsai YF; Lien PJ; Lin YS; Feng CJ; Chen YJ; Cheng HF; Tseng LM; Huang CC
Breast Cancer Res Treat; 2023 Oct; 201(3):547-560. PubMed ID: 37470893
[TBL] [Abstract][Full Text] [Related]
6. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population.
Lim ST; Yu JH; Park HK; Moon BI; Ko BK; Suh YJ
World J Surg Oncol; 2014 Mar; 12():56. PubMed ID: 24621330
[TBL] [Abstract][Full Text] [Related]
8. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
9. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis.
Weiser R; Polychronopoulou E; Hatch SS; Haque W; Ghani HA; He J; Kuo YF; Gradishar WJ; Klimberg VS
Cancer; 2022 May; 128(9):1738-1747. PubMed ID: 35137951
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
[TBL] [Abstract][Full Text] [Related]
12. Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.
Mouabbi JA; Hassan A; Lim B; Hortobagyi GN; Tripathy D; Layman RM
Breast Cancer Res Treat; 2022 Jun; 193(2):253-264. PubMed ID: 35347549
[TBL] [Abstract][Full Text] [Related]
13. Invasive lobular carcinoma: clinicopathological features and subtypes.
Danzinger S; Hielscher N; Izsó M; Metzler J; Trinkl C; Pfeifer C; Tendl-Schulz K; Singer CF
J Int Med Res; 2021 Jun; 49(6):3000605211017039. PubMed ID: 34187216
[TBL] [Abstract][Full Text] [Related]
14. Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population.
Kwon D; Ko BK; Jung SP; Kim HK; Kim EK; Jung YS; Youn HJ; Lee SB
PLoS One; 2022; 17(1):e0262709. PubMed ID: 35051228
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
Lai HW; Tseng LM; Chang TW; Kuo YL; Hsieh CM; Chen ST; Kuo SJ; Su CC; Chen DR
Breast; 2013 Oct; 22(5):968-73. PubMed ID: 23787124
[TBL] [Abstract][Full Text] [Related]
16. The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.
Jung SY; Jeong J; Shin SH; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
BMC Cancer; 2010 Dec; 10():664. PubMed ID: 21126378
[TBL] [Abstract][Full Text] [Related]
17. Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients.
Lohani KR; Hoskin TL; Day CN; Yasir S; Boughey JC; Degnim AC
Ann Surg Oncol; 2024 Feb; 31(2):936-946. PubMed ID: 37872454
[TBL] [Abstract][Full Text] [Related]
18. Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
Chen Z; Yang J; Li S; Lv M; Shen Y; Wang B; Li P; Yi M; Zhao X; Zhang L; Wang L; Yang J
PLoS One; 2017; 12(9):e0182397. PubMed ID: 28863134
[TBL] [Abstract][Full Text] [Related]
19. Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma.
Yoon TI; Jeong J; Lee S; Ryu JM; Lee YJ; Lee JY; Hwang KT; Kim H; Kim S; Lee SB; Ko BS; Lee JW; Son BH; Metzger O; Kim HJ
JAMA Netw Open; 2023 Nov; 6(11):e2342270. PubMed ID: 37938845
[TBL] [Abstract][Full Text] [Related]
20. Invasive Lobular Carcinoma Has Worse Outcome Compared with Invasive Ductal Carcinoma in Stage IV Breast Cancer with Bone-Only Metastasis.
Luo Y; Ma A; Huang S; Yu Y
Breast Care (Basel); 2022 Jun; 17(3):296-305. PubMed ID: 35949419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
